{"schema_version":"secwatch.filing_event.v1","accession":"0001005286-24-000144","form_type":"8-K","ticker":"LFCR","cik":"0001005286","company_name":"LIFECORE BIOMEDICAL, INC. DE","filed_at":"2024-10-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:07.322690+00:00","generated_at":"2026-05-30T19:45:37.817715+00:00","sec_items":["1.01","2.02","3.02","7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Lifecore raises $24.3M via stock sale; Q1 net loss widens to $16.2M, reaffirms FY25 guidance","bullets":["Sold 5,928,775 shares at $4.10 for gross proceeds of $24.3M to investors including Legion Partners, Greenhaven, Wynnefield, 325 Capital.","Q1 FY25 revenue $24.7M (flat YoY); net loss $16.2M ($0.53 per share) vs $10.8M loss prior year.","Adjusted EBITDA $(1.8)M in line with prior year $(2.0)M; FY25 guidance reaffirmed: rev $126.5-130M, Adj EBITDA $19-21M.","Installed 5-head isolator filler doubling capacity to $300M revenue potential; signed four new customers including Lindy Biosciences.","Regained Nasdaq compliance; added two sales reps; plans Investor Day in November to detail medium-term targets."],"urls":{"canonical":"https://secwatch.observer/filing/0001005286-24-000144","json":"https://secwatch.observer/filing/0001005286-24-000144.json","markdown":"https://secwatch.observer/filing/0001005286-24-000144.md","text":"https://secwatch.observer/filing/0001005286-24-000144.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1005286/000100528624000144/0001005286-24-000144-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1005286/000100528624000144/lndc-20241003.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T19:45:37.817715+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}